Fontenay le Fleury, France

Alban Le Monnier


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Alban Le Monnier: Advancing the Field of Infectious Disease

Introduction

Alban Le Monnier is an esteemed inventor based in Fontenay le Fleury, France. He has made significant contributions to the field of infectious diseases, notably through his innovative approaches to diagnosing and treating recurring conditions stemming from infections. With a single patent to his name, his work continues to influence medical practices in this critical area of health.

Latest Patents

Alban Le Monnier holds a patent titled "Predictive Value of Specific Immune Response for Recurrence and Disease Outcome." This invention addresses the methods of diagnosing, treating, and preventing diseases associated with recurrent Clostridium Difficle-associated Diarrhea (CDAD). His research provides valuable insights into how specific immune responses can predict disease recurrence, thereby enhancing patient outcomes.

Career Highlights

Throughout his career, Alban Le Monnier has worked with renowned institutions, including the Institut Pasteur, an internationally recognized center for biomedical research. He has also been affiliated with Université Paris-Sud, where he has contributed to the academic and practical aspects of infectious disease research. His work at these institutions underscores his commitment to advancing medical science.

Collaborations

In advancing his research, Alban Le Monnier has collaborated with notable colleagues, including Marie-Lise Gougeon and Anne Collignon. These collaborations have combined their expertise to tackle challenges in the diagnosis and management of infectious diseases, further promoting innovation in the field.

Conclusion

Alban Le Monnier is a prominent figure in the domain of infectious disease invention, with his patent significantly contributing to advancements in diagnosing and managing CDAD. His work at leading research institutions and collaborations with esteemed colleagues highlight his dedication to improving health outcomes through innovative solutions. His contributions to the field are an inspiration for future research and innovation in combating infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…